Pure Monograph vs Veeva Vault RIM
Veeva Vault RIM is the system of record most regulated pharma sponsors use for registrations, submissions, publishing, and archive. Pure Monograph is molecule intelligence that sits upstream of Vault. Almost every mid-market and enterprise sponsor who evaluates both ends up running them side by side.
Short answer. Vault RIM is your regulated content system — versioning, workflow, eCTD publishing, archive. Pure Monograph is enterprise pharmaceutical intelligence: asset intelligence, Trial Autopsy, Trial Counterfactual. They are not competitive products; they sit at different points in the work.
At a glance
| Dimension | Pure Monograph | Veeva Vault RIM |
|---|---|---|
| Primary deliverable | Source-traced monographs, trial analysis, intelligence briefs | Registrations, Submissions, Submissions Publishing, Submissions Archive content lifecycle |
| Category | Molecule intelligence | Regulated content management / RIM suite |
| Regulatory output | Cited reports exported as Word / PDF; not an eCTD publisher | Validated eCTD publishing, lifecycle control, agency submission |
| AI positioning | Core product from day one | AI Agents for Regulatory scheduled August 2026 on Vault Direct Data |
| Pricing | Free: one named-molecule report. No upload. Enterprise: team workspace. | Enterprise contracts, multi-module suite licensing |
| Engagement model | Self-serve report, then ask us for a team workspace | Enterprise sales, implementation partner engagement |
| Ownership | Burrard Pharmaceutical Enterprises Ltd., Vancouver BC | Veeva Systems Inc. (NYSE: VEEV) |
Where the seam sits
A scientific case lives several lives: assemble the public evidence, review it, version it, then publish. Pure Monograph owns the first life. Vault RIM picks up the artifact at scientific or regulatory review and owns the rest. Nothing about the two products forces an either/or choice.
When Veeva alone is not enough
Teams that rely on Vault RIM still need the public record assembled before a draft enters the vault. Pure Monograph does that assembly and marks DATA GAP where the evidence ends. Vault's own AI agents (August 2026 roadmap) add capability inside Vault — complementary, targeted at content already in the Vault environment.
Frequently asked questions
Does Pure Monograph replace Veeva Vault RIM?
No. Vault RIM is the system of record for registrations, submissions, publishing, and archive. Pure Monograph assembles source-traced reports that can later flow into Vault or another validated eCTD system.
What does the Veeva Vault RIM suite include?
Registrations, Submissions, Submissions Publishing, and Submissions Archive. Veeva has publicly disclosed AI Agents for Regulatory on the Vault Direct Data platform, scheduled for August 2026.
Can I use both?
Yes. Assemble the case in Pure Monograph, then review, version, publish, and archive in Vault RIM.
Why pick Pure Monograph if I already have Vault?
Vault manages content lifecycle but does not assemble the public evidence for a molecule. Pure Monograph does that work first.